Evidence map›Paper›PMID 27615120›Full record

ArticleJournal of veterinary internal medicine2016

Platelet Activation and Clopidogrel Effects on ADP-Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3.

R H L Li, J A Stern, V Ho, F Tablin, S P Harris

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Association between patient signalment and platelet function parameters in cats.The Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Article
  4. Article
  5. Optimization of conditions related to Chrono-log platelet aggregation in feline whole blood.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. P2YInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Role of Personalized Medicine in Companion Animal Cardiology.The Veterinary clinics of North America. Small animal practice · 2023
    Review
  16. Validation of Plateletworks ADP for the ProCyte Dx analyzer.Journal of veterinary internal medicine · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.Journal of feline medicine and surgery · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R H L LiDepartment of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA. rhli@ucdavis.edu.
J A SternDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California Davis, Davis, CA.
V HoDepartment of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA.
F TablinDepartment of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA.
S P HarrisDepartment of Cellular and Molecular Medicine, College of Medicine, University of Arizona, Tucson, AZ.
University of California, Davis · USUniversity of Arizona · US

Funding

Molecular Mechanisms of Disease in a Novel Feline Model of Familial HypertrophicR21HL093603 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HARRIS, SAMANTHA P · 2010 to 2011
$418k
NHLBI NIH HHS R21 HL093603
6 · The paper itself

Abstract

backgroundClopidogrel is commonly prescribed to cats with perceived increased risk of thromboembolic events, but little information exists regarding its antiplatelet effects.

objectiveTo determine effects of clopidogrel on platelet responsiveness in cats with or without the A31P mutation in the MYBPC3 gene. A secondary aim was to characterize variability in feline platelet responses to clopidogrel. ANIMALS: Fourteen healthy cats from a Maine Coon/outbred mixed Domestic cat colony: 8 cats homozygous for A31P mutation in the MYPBC3 gene and 6 wild-type cats without the A31P mutation.

methodsEx vivo study. All cats received clopidogrel (18.75 mg PO q24h) for 14 days. Before and after clopidogrel treatment, adenosine diphosphate (ADP)-induced P-selectin expression was evaluated. ADP- and thrombin-induced platelet aggregation was measured by optical aggregometry (OA). Platelet pVASP and ADP receptor response index (ARRI) were measured by Western blot analysis.

resultsPlatelet activation from cats with the A31P mutation was significantly (P = .0095) increased [35.55% (18.58-48.55) to 58.90% (24.85-69.90)], in response to ADP. Clopidogrel treatment attenuated ADP-induced P-selectin expression and platelet aggregation. ADP- and PGE CONCLUSION AND CLINICAL IMPORTANCE: Clopidogrel is effective at attenuating platelet activation and aggregation in some cats. Cats with A31P mutation had increased platelet activation relative to the variable response seen in wild-type cats.

Indexed as

Adenosine DiphosphateAnimalsCarrier ProteinsCat DiseasesCatsClopidogrelGene Expression RegulationGenetic Predisposition to DiseaseGenotypeMutationMyosin Binding Protein CPlatelet ActivationPlatelet Aggregation InhibitorsThrombosisTiclopidineAdenosine DiphosphateCarrier ProteinsClopidogrelMyosin Binding Protein CPlatelet Aggregation InhibitorsTiclopidineCatHypertrophic cardiomyopathyPlatelet hyper-reactivityThromboembolism

Identifiers

PMID27615120
PMCPMC5032873
OpenAlexW2520077484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.